RoslinCT is a leading global contract development and manufacturing services organization (CDMO) focused on Advanced Cell and Gene Therapies. Established in 2006 and built upon the groundbreaking technology cloning of Dolly the Sheep at the Roslin Institute in 1997, RoslinCT has harnessed cutting-edge science to advance the development of human medicines. With a remarkable heritage in the field, the company has achieved significant milestones, including being among the first in the world to produce clinical-grade human pluripotent stem cells and advancing the first CRISPR edited stem cell-based therapy for a major disease to marketing authorization. Equipped with 22 purpose-built cGMP cell therapy processing suites in Edinburgh, Scotland, and Hopkinton, Massachusetts, RoslinCT provides innovative process and analytical development, cGMP clinical and commercial manufacturing for a range of cell types for both autologous and allogeneic processes, and cGMP iPSC cell line development, gene editing, and differentiation. With tailored CDMO solutions, RoslinCT enables partners to efficiently progress from development to commercialization and deliver life-saving Cell and Gene Therapies worldwide. Discover more about our services at www.roslinct.com.
View Top Employees from Lykan Bioscience - Now RoslinCTWebsite | http://www.roslinct.com |
Revenue | $9 million |
Employees | 238 (238 on RocketReach) |
Founded | 2006 |
Address | 97 South Street, Hopkinton, Massachusetts 01748, US |
Phone | +44 131 658 5180 |
Industry | Biotechnology Research, Business Services General, Clinical Trials, Cutting edge translational GMP services, Business Services, Health Care, Complete portfolio of services to support ATMP manufacture & dev, Manufacturing, World leading isolation & production of new clinical grade pluri, High quality iPS cells as a valuable research tool |
Competitors | Cell Applications, Inc., DefiniGEN, Edinburgh BioQuarter, FUJIFILM Cellular Dynamics, WiCell |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541713 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies |
Looking for a particular Lykan Bioscience - Now RoslinCT employee's phone or email?
The Lykan Bioscience - Now RoslinCT annual revenue was $9 million in 2024.
Peter Coleman is the CEO of Lykan Bioscience - Now RoslinCT.
238 people are employed at Lykan Bioscience - Now RoslinCT.
Lykan Bioscience - Now RoslinCT is based in Hopkinton, Massachusetts.
The NAICS codes for Lykan Bioscience - Now RoslinCT are [54171, 54, 541713, 5417, 541].
The SIC codes for Lykan Bioscience - Now RoslinCT are [873, 87].